Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice

Differentiation

Volumn 70, Issue 9-10, 2002, Pages 624-632

  Foster, Barbara A ^a,d   Evangelou, Andreas ^a   Gingrich, J R ^b   Kaplan, Paula J ^a   DeMayo, Franco ^a   Greenberg, Norman M ^a,c  

^a Dept of Molec and Cellular Biology ^*  (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Dominant negative FGF receptor; FGF 7; KGF; Prostate; Transgenic

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NEUROSECRETORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036993587     PISSN: 03014681     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-0436.2002.700915.x     Document Type: Article

References (38)

1. Abrahamsson, P.A. (1999a) Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer 6:503-519.
2. Abrahamsson, P.A. (1999b) Neuroendocrine differentiation in prostatic carcinoma. Prostate 39:135-148.
3. Alarid, E.T., Rubin, J.S., Young, P., Chedid, M., Ron, D., Aaronson, S.A. and Cunha, G.R. (1994) Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074-1078.
4. Angelsen, A., Syversen, U., Haugen, O.A., Stridsberg, M., Mjolnerod, O.K. and Waldum, H.L. (1997) Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? Prostate 30:1-6.
5. Bang, Y.J., Pirnia, F., Fang, W.G., Kang, W.K., Sartor, O., Whitesell, L., Ha, M.J., Tsokos, M., Sheahan, M.D. and Nguyen, P. (1994) Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 91:5330-5334.
6. Bollito, E., Berruti, A., Bellina, M., Mosca, A., Leonardo, E., Tarabuzzi, R., Cappia, S., Ari, M.M., Tampellini, M., Fontana, D., et al. (2001) Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol 12:S159-S164.
7. Champion-Arnaud, P., Ronsin, C., Gilbert, E., Gesnel, M.C., Houssaint, E. and Breathnach, R. (1991) Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 6:979-987.
8. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
9. Cox, M.E., Deeble, P.D., Lakhani, S. and Parsons, S.J. (1999) Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res 59:3821-3830.
10. Cunha, G.R., Alarid, E.T., Turner, T., Donjacour, A.A., Boutin, E.L. and Foster, B.A. (1992) Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 13:465-475.
11. Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J. and Sugimura, Y. (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362.
12. Dell, K.R. and Williams, L.T. (1992) A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem 267:21225-21229.
13. Elghazi, L., Cras-Meneur, C., Czernichow, P. and Scharfmann, R. (2002) Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc Natl Acad Sci USA 99:3884-3889.
14. Foster, B.A., Gingrich, J.R., Kwon, E.D., Madias, C. and Greenberg, N.M. (1997) Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 57:3325-3330.
15. Gray, T.E., Eisenstein, M., Shimon, T., Givol, D. and Yayon, A. (1995) Molecular modeling based mutagenesis defines ligand binding and specificity determining regions of fibroblast growth factor receptors. Biochemistry 34:10325-10333.
16. Greenberg, N.M., DeMayo, F., Finegold, M.J., Medina, D., Tilley, W.D., Aspinall, J.O., Cunha, G.R., Donjacour, A.A., Matusik, R.J. and Rosen, J.M. (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443.
17. Greenberg, N.M., DeMayo, F.J., Sheppard, P.C., Barrios, R., Lebovitz, R., Finegold, M., Angelopoulou, R., Dodd, J.G., Duckworth, M.L., Rosen, J.M., et al. (1994) The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239.
18. Guate, J.L., Escaf, S., Menendez, C.L., del Valle, M. and Vega, J.A. (1997) Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment. Urol Int 59:149-153.
19. Jahn, R., Schiebler, W., Ouimet, C. and Greengard, P. (1985) A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 82:4137-4141.
20. Johnson, D.E., Lu, J., Chen, H., Werner, S. and Williams, L.T. (1991) The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627-4634.
21. Johnson, D.E. and Williams, L.T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
22. Kadmon, D., Thompson, T.C., Lynch, G.R. and Scardino, P.T. (1991) Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol 146:358-361.
23. Leung, H.Y., Mehta, P., Gray, L.B., Collins, A.T., Robson, C.N. and Neal, D.E. (1997) Keratinocyte growth factor expression in hormone insensitive prostate cancer. Oncogene 15:1115-1120.
24. Matsubara, A., Yasumoto, H. and Usui, T. (1999) Hormone Refractory Prostate Cancer and Fibroblast Growth Factor Receptor. Breast Cancer 6:320-324.
25. McGarvey, T.W. and Stearns, M.E. (1995) Keratinocyte growth factor and receptor mRNA expression in benign and malignant human prostate. Exp Mol Pathol 63:52-62.
26. Miki, T., Bottaro, D.P., Fleming, T.P., Smith, C.L., Burgess, W.H., Chan, A.M. and Aaronson, S.A. (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89:246-250.
27. Peters, K., Werner, S., Liao, X., Wert, S., Whitsett, J. and Williams, L. (1994) Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. Embo J 13:3296-3301.
28. Qiu, Y., Robinson, D., Pretlow, T.G. and Kung, H.J. (1998) Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci USA 95:3644-3649.
29. Rennie, P.S., Bruchovsky, N., Leco, K.J., Sheppard, P.C., McQueen, S.A., Cheng, H., Snoek, R., Hamel, A., Bock, M.E., MacDonald, B.S., et al. (1993) Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7:23-36.
30. Rubin, J.S., Bottaro, D.P., Chedid, M., Miki, T., Ron, D., Cheon, G., Taylor, W.G., Fortney, E., Sakata, H., Finch, P.W., et al. (1995) Keratinocyte growth factor. Cell Biol Int 19:399-411.
31. Sugimura, Y., Foster, B.A., Hom, Y.K., Lipschutz, J.H., Rubin, J.S., Finch, P.W., Aaronson, S.A., Hayashi, N., Kawamura, J. and Cunha, G.R. (1996) Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951.
32. Tarle, M. and Rados, N. (1991) Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay. Prostate 19:23-33.
33. Werner, S., Weinberg, W., Liao, X., Peters, K.G., Blessing, M., Yuspa, S.H., Weiner, R.L. and Williams, L.T. (1993) Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. Embo J 12:2635-2643.
34. Whitacre, D.C., Chauhan, S., Davis, T., Gordon, D., Cress, A.E. and Miesfeld, R.L. (2002) Androgen induction of in vitro prostate cell differentiation. Cell Growth Differ 13:1-11.
35. Wiedenmann, B., Franke, W.W., Kuhn, C., Moll, R. and Gould, V.E. (1986) Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 83:3500-3504.
36. Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S. and McKeehan, W.L. (1993) Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF) - FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522.
37. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F. and McKeehan, W.L. (1992) Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol 6:2123-2128.
38. Zelivianski, S., Verni, M., Moore, C., Kondrikov, D., Taylor, R. and Lin, M.F. (2001) Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 1539:28-43.